As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: May 18, 2011
by Health Day News
A gene allele that increases the risk of Alzheimer’s disease starts to damage the brain 50 years before symptoms of the disease appear, a new study suggests.
An allele is one of two or more forms of a gene.
In 2009, scientists concluded that the clusterin (CLU) gene boosts the chances of Alzheimer’s disease by 16 percent, but it wasn’t clear how it increased risk.
This new study concluded that the C-allele of the CLU gene impairs development of myelin, the protective covering around the axons of neurons in the brain. This impairs brain wiring and can make a person more vulnerable to the onset of Alzheimer’s later in life.
About 88 percent of whites have the CLU C-allele, according to the University of California, Los Angeles (UCLA) researchers.
For this study, they used a newer type of MRI to map the connections in the brains of nearly 400 healthy adults aged 20 to 30. The scans revealed that participants with the CLU C-allele had lower white matter integrity than those with a different variant called the CLU T-allele.
The findings are interesting on several levels, according to senior study author Paul Thompson, a professor of neurology.
“For example, Alzheimer’s has traditionally been considered a disease marked by neuronal cell loss and widespread gray matter atrophy,” he said in a UCLA news release. “But degeneration of the myelin in white matter fiber pathways is more and more being considered a key disease component and another possible pathway to the disease, and this discovery supports that.”
Understanding the effects of the CLU C-allele could lead to ways to intervene and protect the brain in the decades before Alzheimer’s develops, Thompson suggested.
The study appears in the current online edition of the Journal of Neuroscience.
Yale researchers have tested a new method for directly measuring synaptic loss in individuals with Alzheimer’s disease. The method, which uses PET imaging technology to scan for a specific protein in the brain linked to synapses, has...
Sometimes, the hardest part of living with a mental illness isn’t the symptoms, or the management — it’s dealing with stigma from other people. And unfortunately, many people who live with mental illness face stigma...
The root cause of behavioural outbursts in someone with Alzheimer’s disease is mostly due to the decline in the person’s language and communication skills. Outbursts also can be caused by an unmet need or needs. The affected...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.